ResearcherUniversity of California, Los AngelesActive in the last 2 years

Christina Vorvis

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5004609678. Sources: OpenAlex.

Their work

Papers: 3
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 10

Papers, trials and grants by year

2016: 2 papers · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 3

Promoter Methylation Leads to Hepatocyte Nuclear Factor 4A Loss and Pancreatic Cancer Aggressiveness. Co-author DOI 10.1016/j.gastha.2024.04.005 ↗
Transcriptomic and CRISPR/Cas9 technologies reveal FOXA2 as a tumor suppressor gene in pancreatic cancer. Co-author DOI 10.1152/ajpgi.00035.2016 ↗
Developments in miRNA gene signaling pathways in pancreatic cancer. Co-author DOI 10.2217/fon-2015-0050 ↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Dimitrios Iliopoulos · 2 shared papers, 2016–2024 · strength 0.27
- Paper Promoter Methylation Leads to Hepatocyte Nuclear Factor 4A Loss and Pancreatic Cancer Aggressiveness. DOI 10.1016/j.gastha.2024.04.005 ↗
- Paper Developments in miRNA gene signaling pathways in pancreatic cancer. DOI 10.2217/fon-2015-0050 ↗
George A. Poultsides · 2 shared papers, 2016–2024 · strength 0.23
- Paper Promoter Methylation Leads to Hepatocyte Nuclear Factor 4A Loss and Pancreatic Cancer Aggressiveness. DOI 10.1016/j.gastha.2024.04.005 ↗
- Paper Transcriptomic and CRISPR/Cas9 technologies reveal FOXA2 as a tumor suppressor gene in pancreatic cancer. DOI 10.1152/ajpgi.00035.2016 ↗
Maria Hatziapostolou · 2 shared papers, 2016–2024 · strength 0.23
- Paper Promoter Methylation Leads to Hepatocyte Nuclear Factor 4A Loss and Pancreatic Cancer Aggressiveness. DOI 10.1016/j.gastha.2024.04.005 ↗
- Paper Transcriptomic and CRISPR/Cas9 technologies reveal FOXA2 as a tumor suppressor gene in pancreatic cancer. DOI 10.1152/ajpgi.00035.2016 ↗
Dileep N. Lobo · 1 shared paper, 2024 · strength 0.17
- Paper Promoter Methylation Leads to Hepatocyte Nuclear Factor 4A Loss and Pancreatic Cancer Aggressiveness. DOI 10.1016/j.gastha.2024.04.005 ↗
Stephen Jacob Pandol · 1 shared paper, 2024 · strength 0.17
- Paper Promoter Methylation Leads to Hepatocyte Nuclear Factor 4A Loss and Pancreatic Cancer Aggressiveness. DOI 10.1016/j.gastha.2024.04.005 ↗
Mouad Edderkaoui · 1 shared paper, 2024 · strength 0.17
- Paper Promoter Methylation Leads to Hepatocyte Nuclear Factor 4A Loss and Pancreatic Cancer Aggressiveness. DOI 10.1016/j.gastha.2024.04.005 ↗
David W. Dawson · 1 shared paper, 2024 · strength 0.17
- Paper Promoter Methylation Leads to Hepatocyte Nuclear Factor 4A Loss and Pancreatic Cancer Aggressiveness. DOI 10.1016/j.gastha.2024.04.005 ↗
Timothy R. Donahue · 1 shared paper, 2016 · strength 0.06
- Paper Transcriptomic and CRISPR/Cas9 technologies reveal FOXA2 as a tumor suppressor gene in pancreatic cancer. DOI 10.1152/ajpgi.00035.2016 ↗
Dimitrios Iliopoulos · 1 shared paper, 2016 · strength 0.06
- Paper Transcriptomic and CRISPR/Cas9 technologies reveal FOXA2 as a tumor suppressor gene in pancreatic cancer. DOI 10.1152/ajpgi.00035.2016 ↗
Guido Eibl · 1 shared paper, 2016 · strength 0.06
- Paper Transcriptomic and CRISPR/Cas9 technologies reveal FOXA2 as a tumor suppressor gene in pancreatic cancer. DOI 10.1152/ajpgi.00035.2016 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.